QUOMATIC.AI
Transforming Industries with Custom-Built AI Solutions

“Over the next decade, AI won’t replace managers, but managers who use AI will replace those who don’t.” - Erik Brynjolfsson & Andrew McAfee (MIT), Harvard Business Review 2018.

QUOMATIC.AI, with more than two decades of experience in AI and with 100 peer-reviewed publications, helps clients in transforming their data to knowledge. By partnering with the company, the clients can save cost, optimize processes, boost profits and drive innovations.

QUOMATIC follows strategy, build, and run methodology to help their clients realize the true AI potential. As an AI and data strategy consultant, the company has a team of data science experts and machine learning engineers with years of experience covering multiple projects in deep learning, rule-based systems, statistical learning, machine learning, and computer vision. They help clients start their AI journey with elaborate data strategy to suit their unique business goals. QUOMATIC also partners with their clients to help them build innovative AI software to transform their business. Finally, the company helps its clients operate and maintain their AI solutions for better business outcomes.

QUOMATIC cover the full project cycle for their clients beginning with business understanding, data understanding and preparation, modeling, evaluation, and ending with the deployment of the solution.

In addition, they offer AI awareness workshops for the common identification of potential use cases together with their partners.

One major highlight in their AI journey is that QUOMATIC utilizes the global crowd science consisting of machine learning experts, quantitative analysts and data scientists for obtaining innovative ideas that further improve the quality of the AI models. Besides that, the crowd helps to accelerate the project cycle to deliver high-quality AI solutions to their clients without losing time.

QUOMATIC assists clients in healthcare and digital media industries. Over the years, they have developed a novel AI-based risk score heart valve surgery that outperforms established models. The approach serves as a role model of how machine learning/artificial intelligence helps to exploit electronic health records for the patient's benefit. With artificial intelligence, QUOMATIC predicts the allergic reactions of patients to non-steroidal anti-inflammatory drugs (NSAIDs) from genotypes. This model helped in identifying candidate genes that are associated with those allergies. They help to predict antibiotics resistances from the genotypes of Pseudomonas aeruginosa, a common pathogen in hospital-acquired infections. In the digital media arena, QUOMATIC's fully automatic quality control system prints on optical digital media using a multi-method approach. The process combines computer vision, logic and machine learning. The machine learning-based prediction of paper quality from a paper mill’s complex set of parameters helps to optimize the paper production process.

In the coming time, the QUOMATIC team will continue making its platform scalable and offers solutions to more than just healthcare and digital media. "We work in the area of software development to machine learning and offer our client companies the advantage of using our solution thus serving the best to their end user. This has increased the demand for artificial intelligence in the area of healthcare and digital media, to which we power with our system and team" says Dr Franz Juen, CEO of QUOMATIC.AI.